Overview
McDermott Will & Emery assisted DBV Technologies in its $153 million capital increase in connection with (i) a public offering of common shares in the form of American Depositary Shares (“ADS”) in the United States, Canada and certain countries outside of Europe at a price of US$10.25 per ADS, and (ii) an offering of common shares exclusively to qualified investors in Europe (including in France). The Company’s ADSs are admitted to trading on the Nasdaq Global Select Market under the symbol “DBVT” and the Company’s common shares are admitted to trading on the Euronext Paris under the symbol “DBV”.
In this transaction, McDermott Will & Emery acted for DBV Technologies with a team led by partners Emmanuelle Trombe and Bertrand Delafaye, and including associates Stephan de Groër, Baptiste Tigaud and Mathilde Peschard. McDermott Will & Emery had already acted for DBV Technologies in its $143 million global offering completed in October 2019 and in its $81 million global offering completed in April 2019. The Cooley law firm acted for DBV Technologies on American law aspects.
DBA Associés also acted for DBV Technologies.
Gide in France and Goodwin in the United States acted for lead banks and joint bookrunners Goldman Sachs and Citigroup.
For the French version, click here.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With 20 locations on three continents, our team works seamlessly across practices, industries and geographies to deliver highly effective – and often unexpected – solutions that propel success. More than 1,100 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
